nodes	percent_of_prediction	percent_of_DWPC	metapath
Fondaparinux sodium—Abdominal pain—Vandetanib—thyroid cancer	0.00269	0.00269	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Vandetanib—thyroid cancer	0.00269	0.00269	CcSEcCtD
Fondaparinux sodium—Cellulitis—Epirubicin—thyroid cancer	0.00261	0.00261	CcSEcCtD
Fondaparinux sodium—Hyperbilirubinaemia—Epirubicin—thyroid cancer	0.00261	0.00261	CcSEcCtD
Fondaparinux sodium—Anaemia—Sorafenib—thyroid cancer	0.0026	0.0026	CcSEcCtD
Fondaparinux sodium—Hypocalcaemia—Epirubicin—thyroid cancer	0.0026	0.0026	CcSEcCtD
Fondaparinux sodium—Oliguria—Epirubicin—thyroid cancer	0.00258	0.00258	CcSEcCtD
Fondaparinux sodium—Angioedema—Sorafenib—thyroid cancer	0.00257	0.00257	CcSEcCtD
Fondaparinux sodium—Syncope—Sorafenib—thyroid cancer	0.00252	0.00252	CcSEcCtD
Fondaparinux sodium—Extravasation—Doxorubicin—thyroid cancer	0.00252	0.00252	CcSEcCtD
Fondaparinux sodium—Ulcer—Epirubicin—thyroid cancer	0.00251	0.00251	CcSEcCtD
Fondaparinux sodium—Creatinine increased—Epirubicin—thyroid cancer	0.0025	0.0025	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Sorafenib—thyroid cancer	0.00247	0.00247	CcSEcCtD
Fondaparinux sodium—Cough—Sorafenib—thyroid cancer	0.00245	0.00245	CcSEcCtD
Fondaparinux sodium—Asthenia—Vandetanib—thyroid cancer	0.00244	0.00244	CcSEcCtD
Fondaparinux sodium—Cellulitis—Doxorubicin—thyroid cancer	0.00242	0.00242	CcSEcCtD
Fondaparinux sodium—Hyperbilirubinaemia—Doxorubicin—thyroid cancer	0.00242	0.00242	CcSEcCtD
Fondaparinux sodium—Pruritus—Vandetanib—thyroid cancer	0.00241	0.00241	CcSEcCtD
Fondaparinux sodium—Hypocalcaemia—Doxorubicin—thyroid cancer	0.0024	0.0024	CcSEcCtD
Fondaparinux sodium—Oliguria—Doxorubicin—thyroid cancer	0.00239	0.00239	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00238	0.00238	CcSEcCtD
Fondaparinux sodium—Hepatocellular injury—Epirubicin—thyroid cancer	0.00238	0.00238	CcSEcCtD
Fondaparinux sodium—Ventricular tachycardia—Epirubicin—thyroid cancer	0.00238	0.00238	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Vandetanib—thyroid cancer	0.00233	0.00233	CcSEcCtD
Fondaparinux sodium—Ulcer—Doxorubicin—thyroid cancer	0.00232	0.00232	CcSEcCtD
Fondaparinux sodium—Creatinine increased—Doxorubicin—thyroid cancer	0.00231	0.00231	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Sorafenib—thyroid cancer	0.00229	0.00229	CcSEcCtD
Fondaparinux sodium—Infection—Sorafenib—thyroid cancer	0.00228	0.00228	CcSEcCtD
Fondaparinux sodium—Shock—Sorafenib—thyroid cancer	0.00226	0.00226	CcSEcCtD
Fondaparinux sodium—Fluid retention—Epirubicin—thyroid cancer	0.00226	0.00226	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Sorafenib—thyroid cancer	0.00225	0.00225	CcSEcCtD
Fondaparinux sodium—Dizziness—Vandetanib—thyroid cancer	0.00225	0.00225	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Sorafenib—thyroid cancer	0.00225	0.00225	CcSEcCtD
Fondaparinux sodium—Blood urea increased—Epirubicin—thyroid cancer	0.00224	0.00224	CcSEcCtD
Fondaparinux sodium—Skin disorder—Sorafenib—thyroid cancer	0.00223	0.00223	CcSEcCtD
Fondaparinux sodium—Hepatocellular injury—Doxorubicin—thyroid cancer	0.0022	0.0022	CcSEcCtD
Fondaparinux sodium—Ventricular tachycardia—Doxorubicin—thyroid cancer	0.0022	0.0022	CcSEcCtD
Fondaparinux sodium—Anorexia—Sorafenib—thyroid cancer	0.00219	0.00219	CcSEcCtD
Fondaparinux sodium—Vomiting—Vandetanib—thyroid cancer	0.00216	0.00216	CcSEcCtD
Fondaparinux sodium—Rash—Vandetanib—thyroid cancer	0.00214	0.00214	CcSEcCtD
Fondaparinux sodium—Dermatitis—Vandetanib—thyroid cancer	0.00214	0.00214	CcSEcCtD
Fondaparinux sodium—Headache—Vandetanib—thyroid cancer	0.00213	0.00213	CcSEcCtD
Fondaparinux sodium—Fluid retention—Doxorubicin—thyroid cancer	0.00209	0.00209	CcSEcCtD
Fondaparinux sodium—Blood urea increased—Doxorubicin—thyroid cancer	0.00208	0.00208	CcSEcCtD
Fondaparinux sodium—Sepsis—Epirubicin—thyroid cancer	0.00206	0.00206	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Sorafenib—thyroid cancer	0.00205	0.00205	CcSEcCtD
Fondaparinux sodium—Nausea—Vandetanib—thyroid cancer	0.00202	0.00202	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Sorafenib—thyroid cancer	0.00202	0.00202	CcSEcCtD
Fondaparinux sodium—Phlebitis—Epirubicin—thyroid cancer	0.002	0.002	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Sorafenib—thyroid cancer	0.00199	0.00199	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00198	0.00198	CcSEcCtD
Fondaparinux sodium—Fatigue—Sorafenib—thyroid cancer	0.00198	0.00198	CcSEcCtD
Fondaparinux sodium—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00197	0.00197	CcSEcCtD
Fondaparinux sodium—Pain—Sorafenib—thyroid cancer	0.00196	0.00196	CcSEcCtD
Fondaparinux sodium—Constipation—Sorafenib—thyroid cancer	0.00196	0.00196	CcSEcCtD
Fondaparinux sodium—Vascular purpura—Epirubicin—thyroid cancer	0.00193	0.00193	CcSEcCtD
Fondaparinux sodium—Sepsis—Doxorubicin—thyroid cancer	0.00191	0.00191	CcSEcCtD
Fondaparinux sodium—Cardiac failure congestive—Epirubicin—thyroid cancer	0.0019	0.0019	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00188	0.00188	CcSEcCtD
Fondaparinux sodium—Renal failure acute—Epirubicin—thyroid cancer	0.00187	0.00187	CcSEcCtD
Fondaparinux sodium—Phlebitis—Doxorubicin—thyroid cancer	0.00185	0.00185	CcSEcCtD
Fondaparinux sodium—Hot flush—Epirubicin—thyroid cancer	0.00184	0.00184	CcSEcCtD
Fondaparinux sodium—Menopausal symptoms—Epirubicin—thyroid cancer	0.00183	0.00183	CcSEcCtD
Fondaparinux sodium—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.00183	0.00183	CcSEcCtD
Fondaparinux sodium—Urticaria—Sorafenib—thyroid cancer	0.00182	0.00182	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Sorafenib—thyroid cancer	0.00181	0.00181	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Sorafenib—thyroid cancer	0.00181	0.00181	CcSEcCtD
Fondaparinux sodium—Renal impairment—Epirubicin—thyroid cancer	0.00181	0.00181	CcSEcCtD
Fondaparinux sodium—Dermatitis bullous—Epirubicin—thyroid cancer	0.0018	0.0018	CcSEcCtD
Fondaparinux sodium—Purpura—Epirubicin—thyroid cancer	0.00179	0.00179	CcSEcCtD
Fondaparinux sodium—Vascular purpura—Doxorubicin—thyroid cancer	0.00178	0.00178	CcSEcCtD
Fondaparinux sodium—Cardiac failure—Epirubicin—thyroid cancer	0.00177	0.00177	CcSEcCtD
Fondaparinux sodium—Cerebrovascular accident—Epirubicin—thyroid cancer	0.00176	0.00176	CcSEcCtD
Fondaparinux sodium—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.00176	0.00176	CcSEcCtD
Fondaparinux sodium—Renal failure acute—Doxorubicin—thyroid cancer	0.00173	0.00173	CcSEcCtD
Fondaparinux sodium—Pain in extremity—Epirubicin—thyroid cancer	0.00172	0.00172	CcSEcCtD
Fondaparinux sodium—Hot flush—Doxorubicin—thyroid cancer	0.00171	0.00171	CcSEcCtD
Fondaparinux sodium—Menopausal symptoms—Doxorubicin—thyroid cancer	0.00169	0.00169	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Sorafenib—thyroid cancer	0.00169	0.00169	CcSEcCtD
Fondaparinux sodium—Renal impairment—Doxorubicin—thyroid cancer	0.00168	0.00168	CcSEcCtD
Fondaparinux sodium—Dermatitis bullous—Doxorubicin—thyroid cancer	0.00167	0.00167	CcSEcCtD
Fondaparinux sodium—Purpura—Doxorubicin—thyroid cancer	0.00166	0.00166	CcSEcCtD
Fondaparinux sodium—Asthenia—Sorafenib—thyroid cancer	0.00165	0.00165	CcSEcCtD
Fondaparinux sodium—Cardiac arrest—Epirubicin—thyroid cancer	0.00164	0.00164	CcSEcCtD
Fondaparinux sodium—Cardiac failure—Doxorubicin—thyroid cancer	0.00164	0.00164	CcSEcCtD
Fondaparinux sodium—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00163	0.00163	CcSEcCtD
Fondaparinux sodium—Pruritus—Sorafenib—thyroid cancer	0.00162	0.00162	CcSEcCtD
Fondaparinux sodium—Blood creatinine increased—Epirubicin—thyroid cancer	0.00162	0.00162	CcSEcCtD
Fondaparinux sodium—Dehydration—Epirubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Fondaparinux sodium—Pain in extremity—Doxorubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Fondaparinux sodium—Hypokalaemia—Epirubicin—thyroid cancer	0.00157	0.00157	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Sorafenib—thyroid cancer	0.00157	0.00157	CcSEcCtD
Fondaparinux sodium—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00155	0.00155	CcSEcCtD
Fondaparinux sodium—Gastritis—Epirubicin—thyroid cancer	0.00153	0.00153	CcSEcCtD
Fondaparinux sodium—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.00152	0.00152	CcSEcCtD
Fondaparinux sodium—Cardiac arrest—Doxorubicin—thyroid cancer	0.00152	0.00152	CcSEcCtD
Fondaparinux sodium—Dizziness—Sorafenib—thyroid cancer	0.00152	0.00152	CcSEcCtD
Fondaparinux sodium—Abdominal distension—Epirubicin—thyroid cancer	0.0015	0.0015	CcSEcCtD
Fondaparinux sodium—Blood creatinine increased—Doxorubicin—thyroid cancer	0.0015	0.0015	CcSEcCtD
Fondaparinux sodium—Dysphagia—Epirubicin—thyroid cancer	0.00149	0.00149	CcSEcCtD
Fondaparinux sodium—Dehydration—Doxorubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Fondaparinux sodium—Vomiting—Sorafenib—thyroid cancer	0.00146	0.00146	CcSEcCtD
Fondaparinux sodium—Hypokalaemia—Doxorubicin—thyroid cancer	0.00145	0.00145	CcSEcCtD
Fondaparinux sodium—Rash—Sorafenib—thyroid cancer	0.00145	0.00145	CcSEcCtD
Fondaparinux sodium—Dermatitis—Sorafenib—thyroid cancer	0.00144	0.00144	CcSEcCtD
Fondaparinux sodium—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.00144	0.00144	CcSEcCtD
Fondaparinux sodium—Headache—Sorafenib—thyroid cancer	0.00144	0.00144	CcSEcCtD
Fondaparinux sodium—Bronchitis—Epirubicin—thyroid cancer	0.00143	0.00143	CcSEcCtD
Fondaparinux sodium—Gastritis—Doxorubicin—thyroid cancer	0.00141	0.00141	CcSEcCtD
Fondaparinux sodium—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.00141	0.00141	CcSEcCtD
Fondaparinux sodium—Abdominal distension—Doxorubicin—thyroid cancer	0.00139	0.00139	CcSEcCtD
Fondaparinux sodium—Dysphagia—Doxorubicin—thyroid cancer	0.00138	0.00138	CcSEcCtD
Fondaparinux sodium—Nausea—Sorafenib—thyroid cancer	0.00136	0.00136	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Epirubicin—thyroid cancer	0.00133	0.00133	CcSEcCtD
Fondaparinux sodium—Infestation—Epirubicin—thyroid cancer	0.00133	0.00133	CcSEcCtD
Fondaparinux sodium—Bronchitis—Doxorubicin—thyroid cancer	0.00133	0.00133	CcSEcCtD
Fondaparinux sodium—Renal failure—Epirubicin—thyroid cancer	0.00131	0.00131	CcSEcCtD
Fondaparinux sodium—Urinary tract infection—Epirubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Fondaparinux sodium—Haematuria—Epirubicin—thyroid cancer	0.00127	0.00127	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Epirubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Fondaparinux sodium—Epistaxis—Epirubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Doxorubicin—thyroid cancer	0.00123	0.00123	CcSEcCtD
Fondaparinux sodium—Infestation—Doxorubicin—thyroid cancer	0.00123	0.00123	CcSEcCtD
Fondaparinux sodium—Renal failure—Doxorubicin—thyroid cancer	0.00121	0.00121	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Epirubicin—thyroid cancer	0.0012	0.0012	CcSEcCtD
Fondaparinux sodium—Urinary tract infection—Doxorubicin—thyroid cancer	0.0012	0.0012	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Epirubicin—thyroid cancer	0.00119	0.00119	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Epirubicin—thyroid cancer	0.00119	0.00119	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Epirubicin—thyroid cancer	0.00118	0.00118	CcSEcCtD
Fondaparinux sodium—Haematuria—Doxorubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Fondaparinux sodium—Epistaxis—Doxorubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Doxorubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Fondaparinux sodium—Flushing—Epirubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Doxorubicin—thyroid cancer	0.0011	0.0011	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Doxorubicin—thyroid cancer	0.0011	0.0011	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Doxorubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Fondaparinux sodium—Angiopathy—Epirubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Epirubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Epirubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Epirubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Fondaparinux sodium—Malnutrition—Epirubicin—thyroid cancer	0.00104	0.00104	CcSEcCtD
Fondaparinux sodium—Flushing—Doxorubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Fondaparinux sodium—Flatulence—Epirubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Epirubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Fondaparinux sodium—Back pain—Epirubicin—thyroid cancer	0.001	0.001	CcSEcCtD
Fondaparinux sodium—Angiopathy—Doxorubicin—thyroid cancer	0.001	0.001	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Doxorubicin—thyroid cancer	0.000997	0.000997	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000995	0.000995	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Doxorubicin—thyroid cancer	0.000986	0.000986	CcSEcCtD
Fondaparinux sodium—Vision blurred—Epirubicin—thyroid cancer	0.000979	0.000979	CcSEcCtD
Fondaparinux sodium—Malnutrition—Doxorubicin—thyroid cancer	0.000961	0.000961	CcSEcCtD
Fondaparinux sodium—Anaemia—Epirubicin—thyroid cancer	0.00096	0.00096	CcSEcCtD
Fondaparinux sodium—Flatulence—Doxorubicin—thyroid cancer	0.000947	0.000947	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Doxorubicin—thyroid cancer	0.000941	0.000941	CcSEcCtD
Fondaparinux sodium—Vertigo—Epirubicin—thyroid cancer	0.000933	0.000933	CcSEcCtD
Fondaparinux sodium—Syncope—Epirubicin—thyroid cancer	0.000931	0.000931	CcSEcCtD
Fondaparinux sodium—Back pain—Doxorubicin—thyroid cancer	0.00093	0.00093	CcSEcCtD
Fondaparinux sodium—Palpitations—Epirubicin—thyroid cancer	0.000918	0.000918	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Epirubicin—thyroid cancer	0.000913	0.000913	CcSEcCtD
Fondaparinux sodium—Cough—Epirubicin—thyroid cancer	0.000906	0.000906	CcSEcCtD
Fondaparinux sodium—Vision blurred—Doxorubicin—thyroid cancer	0.000906	0.000906	CcSEcCtD
Fondaparinux sodium—Convulsion—Epirubicin—thyroid cancer	0.0009	0.0009	CcSEcCtD
Fondaparinux sodium—Anaemia—Doxorubicin—thyroid cancer	0.000888	0.000888	CcSEcCtD
Fondaparinux sodium—Chest pain—Epirubicin—thyroid cancer	0.000884	0.000884	CcSEcCtD
Fondaparinux sodium—Anxiety—Epirubicin—thyroid cancer	0.000881	0.000881	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000878	0.000878	CcSEcCtD
Fondaparinux sodium—Vertigo—Doxorubicin—thyroid cancer	0.000863	0.000863	CcSEcCtD
Fondaparinux sodium—Syncope—Doxorubicin—thyroid cancer	0.000862	0.000862	CcSEcCtD
Fondaparinux sodium—Confusional state—Epirubicin—thyroid cancer	0.000855	0.000855	CcSEcCtD
Fondaparinux sodium—Palpitations—Doxorubicin—thyroid cancer	0.000849	0.000849	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Epirubicin—thyroid cancer	0.000848	0.000848	CcSEcCtD
Fondaparinux sodium—Oedema—Epirubicin—thyroid cancer	0.000848	0.000848	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Doxorubicin—thyroid cancer	0.000845	0.000845	CcSEcCtD
Fondaparinux sodium—Infection—Epirubicin—thyroid cancer	0.000842	0.000842	CcSEcCtD
Fondaparinux sodium—Cough—Doxorubicin—thyroid cancer	0.000839	0.000839	CcSEcCtD
Fondaparinux sodium—Shock—Epirubicin—thyroid cancer	0.000834	0.000834	CcSEcCtD
Fondaparinux sodium—Convulsion—Doxorubicin—thyroid cancer	0.000833	0.000833	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Epirubicin—thyroid cancer	0.000831	0.000831	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Epirubicin—thyroid cancer	0.00083	0.00083	CcSEcCtD
Fondaparinux sodium—Tachycardia—Epirubicin—thyroid cancer	0.000827	0.000827	CcSEcCtD
Fondaparinux sodium—Skin disorder—Epirubicin—thyroid cancer	0.000823	0.000823	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Epirubicin—thyroid cancer	0.00082	0.00082	CcSEcCtD
Fondaparinux sodium—Chest pain—Doxorubicin—thyroid cancer	0.000818	0.000818	CcSEcCtD
Fondaparinux sodium—Anxiety—Doxorubicin—thyroid cancer	0.000815	0.000815	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000813	0.000813	CcSEcCtD
Fondaparinux sodium—Anorexia—Epirubicin—thyroid cancer	0.000808	0.000808	CcSEcCtD
Fondaparinux sodium—Hypotension—Epirubicin—thyroid cancer	0.000792	0.000792	CcSEcCtD
Fondaparinux sodium—Confusional state—Doxorubicin—thyroid cancer	0.000791	0.000791	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000784	0.000784	CcSEcCtD
Fondaparinux sodium—Oedema—Doxorubicin—thyroid cancer	0.000784	0.000784	CcSEcCtD
Fondaparinux sodium—Infection—Doxorubicin—thyroid cancer	0.000779	0.000779	CcSEcCtD
Fondaparinux sodium—Shock—Doxorubicin—thyroid cancer	0.000772	0.000772	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Doxorubicin—thyroid cancer	0.000769	0.000769	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000768	0.000768	CcSEcCtD
Fondaparinux sodium—Insomnia—Epirubicin—thyroid cancer	0.000767	0.000767	CcSEcCtD
Fondaparinux sodium—Tachycardia—Doxorubicin—thyroid cancer	0.000766	0.000766	CcSEcCtD
Fondaparinux sodium—Skin disorder—Doxorubicin—thyroid cancer	0.000762	0.000762	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Epirubicin—thyroid cancer	0.000761	0.000761	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000758	0.000758	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Epirubicin—thyroid cancer	0.000756	0.000756	CcSEcCtD
Fondaparinux sodium—Somnolence—Epirubicin—thyroid cancer	0.000754	0.000754	CcSEcCtD
Fondaparinux sodium—Anorexia—Doxorubicin—thyroid cancer	0.000748	0.000748	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Epirubicin—thyroid cancer	0.000746	0.000746	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Epirubicin—thyroid cancer	0.000737	0.000737	CcSEcCtD
Fondaparinux sodium—Hypotension—Doxorubicin—thyroid cancer	0.000733	0.000733	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000732	0.000732	CcSEcCtD
Fondaparinux sodium—Fatigue—Epirubicin—thyroid cancer	0.000731	0.000731	CcSEcCtD
Fondaparinux sodium—Pain—Epirubicin—thyroid cancer	0.000725	0.000725	CcSEcCtD
Fondaparinux sodium—Constipation—Epirubicin—thyroid cancer	0.000725	0.000725	CcSEcCtD
Fondaparinux sodium—Insomnia—Doxorubicin—thyroid cancer	0.000709	0.000709	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Doxorubicin—thyroid cancer	0.000704	0.000704	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Doxorubicin—thyroid cancer	0.000699	0.000699	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Epirubicin—thyroid cancer	0.000699	0.000699	CcSEcCtD
Fondaparinux sodium—Somnolence—Doxorubicin—thyroid cancer	0.000697	0.000697	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000693	0.000693	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Doxorubicin—thyroid cancer	0.00069	0.00069	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Doxorubicin—thyroid cancer	0.000682	0.000682	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000677	0.000677	CcSEcCtD
Fondaparinux sodium—Fatigue—Doxorubicin—thyroid cancer	0.000676	0.000676	CcSEcCtD
Fondaparinux sodium—Urticaria—Epirubicin—thyroid cancer	0.000673	0.000673	CcSEcCtD
Fondaparinux sodium—Pain—Doxorubicin—thyroid cancer	0.000671	0.000671	CcSEcCtD
Fondaparinux sodium—Constipation—Doxorubicin—thyroid cancer	0.000671	0.000671	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Epirubicin—thyroid cancer	0.00067	0.00067	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Epirubicin—thyroid cancer	0.00067	0.00067	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Doxorubicin—thyroid cancer	0.000646	0.000646	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000641	0.000641	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Epirubicin—thyroid cancer	0.000625	0.000625	CcSEcCtD
Fondaparinux sodium—Urticaria—Doxorubicin—thyroid cancer	0.000623	0.000623	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Doxorubicin—thyroid cancer	0.00062	0.00062	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Doxorubicin—thyroid cancer	0.00062	0.00062	CcSEcCtD
Fondaparinux sodium—Asthenia—Epirubicin—thyroid cancer	0.000608	0.000608	CcSEcCtD
Fondaparinux sodium—Pruritus—Epirubicin—thyroid cancer	0.0006	0.0006	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Epirubicin—thyroid cancer	0.00058	0.00058	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Doxorubicin—thyroid cancer	0.000578	0.000578	CcSEcCtD
Fondaparinux sodium—Asthenia—Doxorubicin—thyroid cancer	0.000563	0.000563	CcSEcCtD
Fondaparinux sodium—Dizziness—Epirubicin—thyroid cancer	0.000561	0.000561	CcSEcCtD
Fondaparinux sodium—Pruritus—Doxorubicin—thyroid cancer	0.000555	0.000555	CcSEcCtD
Fondaparinux sodium—Vomiting—Epirubicin—thyroid cancer	0.000539	0.000539	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Doxorubicin—thyroid cancer	0.000537	0.000537	CcSEcCtD
Fondaparinux sodium—Rash—Epirubicin—thyroid cancer	0.000535	0.000535	CcSEcCtD
Fondaparinux sodium—Dermatitis—Epirubicin—thyroid cancer	0.000534	0.000534	CcSEcCtD
Fondaparinux sodium—Headache—Epirubicin—thyroid cancer	0.000531	0.000531	CcSEcCtD
Fondaparinux sodium—Dizziness—Doxorubicin—thyroid cancer	0.000519	0.000519	CcSEcCtD
Fondaparinux sodium—Nausea—Epirubicin—thyroid cancer	0.000504	0.000504	CcSEcCtD
Fondaparinux sodium—Vomiting—Doxorubicin—thyroid cancer	0.000499	0.000499	CcSEcCtD
Fondaparinux sodium—Rash—Doxorubicin—thyroid cancer	0.000495	0.000495	CcSEcCtD
Fondaparinux sodium—Dermatitis—Doxorubicin—thyroid cancer	0.000494	0.000494	CcSEcCtD
Fondaparinux sodium—Headache—Doxorubicin—thyroid cancer	0.000491	0.000491	CcSEcCtD
Fondaparinux sodium—Nausea—Doxorubicin—thyroid cancer	0.000466	0.000466	CcSEcCtD
